Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Indigo Paints Limited (INDIGOPNTS.NS)
Pune, IN
Indigo Paints Limited specializes in the development, manufacturing, and distribution of decorative paint products. The company serves a broad customer base, both within India and across international markets. Its comprehensive product line features a diverse range of decorative solutions, including interior and exterior emulsions, enamels, wall putties, primers, and premium wood finishes. Furthermore, Indigo Paints offers a variety of specialized items, such as water-resistant emulsions, aluminium paints, coatings for stone and tiles, roof paints, and various tinting solutions. The company was founded in 2000 and operates primarily from its headquarters located in Pune, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.56% | +0.24% | +15.15% | +4.52% | -24.21% | -13.42% | -5.27% | -34.30% | -61.50% | -68.23% | -68.23% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | +1 |
| Hold | 1 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 2 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.8% ★ Q1'26: +9.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+1.7% Q1'26: +1.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.7% Q1'26: +2.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+13.9% ★ Q1'26: +18.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+17.2% ★ Q1'26: +28.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.6% Q1'26: +0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.08× ★ Q1'26: 0.06× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 7 Rev. Ana. 5 EPS Ana. |
Mar 2027 4 Rev. Ana. 6 EPS Ana. |
Mar 2028 7 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
7.20B
est: 7.25B (-0.7%)
|
9.01B
est: 9.49B (-5.0%)
|
10.73B
est: 10.69B (+0.4%)
|
13.00B
est: 13.29B (-2.1%)
|
13.41B
est: 13.56B (-1.1%)
|
13.92B
13.20B – 14.11B
+2.6% YoY
|
15.76B
15.02B – 16.90B
+13.2% YoY
|
17.46B
16.32B – 18.61B
+10.8% YoY
|
| EBITDA |
1.25B
est: 1.30B (-3.4%)
|
1.46B
est: 1.70B (-14.2%)
|
1.90B
est: 1.91B (-0.6%)
|
2.52B
est: 2.73B (-7.7%)
|
2.52B
est: 2.79B (-9.7%)
|
2.86B
2.72B – 2.90B
+2.6% YoY
|
3.24B
3.09B – 3.48B
+13.2% YoY
|
3.59B
3.36B – 3.83B
+10.8% YoY
|
| EBIT |
981.56M
est: 1.03B (-4.8%)
|
1.14B
est: 1.35B (-15.2%)
|
1.56B
est: 1.52B (+2.5%)
|
2.01B
est: 1.98B (+1.1%)
|
1.93B
est: 2.03B (-4.5%)
|
2.08B
1.97B – 2.11B
+2.6% YoY
|
2.35B
2.24B – 2.53B
+13.2% YoY
|
2.61B
2.44B – 2.78B
+10.8% YoY
|
| Net Income |
708.50M
est: 950.92M (-25.5%)
|
840.48M
est: 1.02B (-17.9%)
|
1.32B
est: 1.15B (+15.0%)
|
1.47B
est: 1.42B (+3.4%)
|
1.42B
est: 1.41B (+0.2%)
|
1.60B
1.54B – 1.66B
+13.2% YoY
|
1.79B
1.48B – 1.90B
+11.9% YoY
|
2.02B
1.64B – 2.29B
+12.8% YoY
|
| SGA |
1.51B
est: 1.29B (+17.3%)
|
1.71B
est: 1.68B (+1.7%)
|
1.82B
est: 1.90B (-4.1%)
|
2.22B
est: 2.32B (-3.9%)
|
1.98B
est: 2.36B (-16.4%)
|
2.43B
2.30B – 2.46B
+2.6% YoY
|
2.75B
2.62B – 2.95B
+13.2% YoY
|
3.04B
2.85B – 3.24B
+10.8% YoY
|
| EPS |
15.55
est: 20.00 (-22.3%)
|
17.67
est: 21.53 (-17.9%)
|
27.73
est: 24.13 (+14.9%)
|
30.95
est: 29.93 (+3.4%)
|
29.89
est: 29.01 (+3.0%)
|
33.46
32.30 – 34.68
+15.3% YoY
|
36.86
30.99 – 39.65
+10.2% YoY
|
42.85
34.34 – 47.81
+16.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hemant Kamala Jalan | Chairman & MD | 36M | male |
| Narayanankutty Kottiedath Venugopal | Executive Director | 18M | male |
| Sayalee Anil Yengul | Company Secretary & Compliance Officer | 948.0K | female |
| Surendra Suresh-Babu Thundiyil | Chief Operating Officer | — | male |
| Pavan Sharma | General Manager of Technical | — | male |
| Chetan Bhalchandra Human | Chief Financial Officer | — | male |
| Srihari Santhakumar | Head of Investor Relations & GM of Finance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for INDIGOPNTS.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
